Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA. 2002 Dec 18; 288(23):2998-3007.

View in: PubMed

subject areas

Aged
Anticholesteremic Agents
Cardiovascular Diseases
Cause of Death
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypercholesterolemia
Hypertension
Lipids
Male
Middle Aged
Pravastatin
Proportional Hazards Models
Risk Factors

authors with profiles

Jeff D. Williamson MD, MHS